Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. Learn more about REPL stock here.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The West Virginia State Penitentiary, a former maximum-security prison that once held far more inmates than it was built for, continues to draw thousands of vis ...

WTOV NBC 9 provides local news, weather forecasts, notices of events and items of interest in the community, sports and entertainment programming for Steubenville and nearby towns and communities in ...

Baker Brothers’ Q1 2026 13F portfolio rose to $17.42B, with top five holdings—Incyte, BeOne Medicines, Insmed, Madrigal ...

Safari Technology Preview 248 delivers native BigInt Math as a JavaScript built-in for the first time, eliminating ...

Will Patterson crunches the numbers to see whether a viable alternative to Brobbey is currently available.

A group of New Mexico Democratic Party insiders will meet this weekend to begin the process of filling a rare ballot vacancy on their gubernatorial ticket. The run-up to the meeting to ...

Busan city government announced Friday it will abolish the long-standing practice of rotating all civil servants through ...

Arsenal are closing in on a deal to sign Christos Tzolis from Club Brugge, having reached an agreement to sign the winger for ...

Presentation and live Q&A to be held after market close on Thursday, August 13, 2026BOSTON, July 23, 2026 (GLOBE NEWSWIRE) -- Merlin, Inc. (Nasdaq: MRLN) today announced that it has plans to host a ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...